3-n-methylspiperone has been researched along with Nerve Degeneration in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fowler, JS; Gatley, SJ; Hitzemann, R; Logan, J; MacGregor, RR; Schlyer, DJ; Volkow, ND; Wang, GJ; Wolf, AP | 1 |
1 other study(ies) available for 3-n-methylspiperone and Nerve Degeneration
Article | Year |
---|---|
Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol.
Topics: Adult; Age Factors; Aged; Aging; Cerebellum; Corpus Striatum; Dopamine Agonists; Female; Humans; Ligands; Male; Middle Aged; Nerve Degeneration; Raclopride; Receptors, Dopamine D2; Salicylamides; Spiperone; Tomography, Emission-Computed | 1996 |